Paul Gurbel to Platelet Aggregation Inhibitors
This is a "connection" page, showing publications Paul Gurbel has written about Platelet Aggregation Inhibitors.
Connection Strength
4.283
-
"Blueprinting" thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke. J Thromb Thrombolysis. 2019 Feb; 47(2):192-199.
Score: 0.354
-
Is There a Role for Preoperative Platelet Function Testing in Patients Undergoing Cardiac Surgery During Antiplatelet Therapy? Circulation. 2018 11 06; 138(19):2145-2159.
Score: 0.349
-
Cangrelor for the treatment of patients with Arterial Thrombosis. Expert Opin Pharmacother. 2018 Aug; 19(12):1389-1398.
Score: 0.343
-
Dual vs single antiplatelet therapy in patients with lower extremity peripheral artery disease - A meta-analysis. Int J Cardiol. 2018 Oct 15; 269:292-297.
Score: 0.340
-
Peri-Procedural Platelet Reactivity in Percutaneous Coronary Intervention. Thromb Haemost. 2018 Jul; 118(7):1131-1140.
Score: 0.338
-
Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments. Expert Opin Pharmacother. 2018 05; 19(7):653-665.
Score: 0.335
-
Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery-The BIANCA Observational Study. Thromb Haemost. 2018 05; 118(5):864-872.
Score: 0.335
-
Thromboembolism after WATCHMANTM in a clopidogrel non-responder: A case for concern? Catheter Cardiovasc Interv. 2018 07; 92(1):200-202.
Score: 0.326
-
Bedside thromboelastography to rapidly assess the pharmacodynamic response of anticoagulants and aspirin in COVID-19: evidence of inadequate therapy in a predominantly minority population. J Thromb Thrombolysis. 2021 May; 51(4):902-904.
Score: 0.103
-
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(4):203-210.
Score: 0.098
-
Secondary prevention of ischaemic stroke: more evidence to block two pathways affecting platelet activation. Eur Heart J Qual Care Clin Outcomes. 2019 10 01; 5(4):275-278.
Score: 0.093
-
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population. Circ Cardiovasc Interv. 2018 10; 11(10):e006853.
Score: 0.087
-
Acetylsalicylic acid and clopidogrel hyporesponsiveness following acute coronary syndromes. Kardiol Pol. 2018; 76(9):1312-1319.
Score: 0.086
-
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial). Am J Cardiol. 2018 10 15; 122(8):1322-1329.
Score: 0.085
-
Evaluation of potential antiplatelet effects of CSL112 (Apolipoprotein A-I [Human]) in patients with atherosclerosis: results from a phase 2a study. J Thromb Thrombolysis. 2018 May; 45(4):469-476.
Score: 0.084
-
Thromboxane inhibition during concurrent therapy with low-dose aspirin and over-the-counter naproxen sodium. J Thromb Thrombolysis. 2018 Jan; 45(1):18-26.
Score: 0.082
-
Should Antithrombotic Treatment Strategies in East Asians Differ from Caucasians? Curr Vasc Pharmacol. 2018; 16(5):459-476.
Score: 0.082
-
International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies. Circulation. 2017 Nov 14; 136(20):1955-1975.
Score: 0.081
-
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors. Eur Heart J Cardiovasc Pharmacother. 2017 10 01; 3(4):221-234.
Score: 0.081
-
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study. JACC Cardiovasc Interv. 2017 08 28; 10(16):1607-1617.
Score: 0.080
-
HIV infection, ACS, PCI and high platelet reactivity: ingredients for a perfect thrombotic storm. Eur Heart J. 2017 06 01; 38(21):1687-1689.
Score: 0.079
-
ANTARCTIC: platelet function testing to adjust therapy. Lancet. 2017 03 25; 389(10075):1193.
Score: 0.078
-
GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes. Lancet. 2017 05 06; 389(10081):1773-1775.
Score: 0.078
-
Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial. Thromb Haemost. 2017 05 03; 117(5):911-922.
Score: 0.077
-
Immunity to thrombotic events is achievable if we stop the guessing game: is this the major hidden message from GRAVITAS? Thromb Haemost. 2011 Aug; 106(2):263-4.
Score: 0.052
-
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010 Sep 14; 56(12):919-33.
Score: 0.050
-
Platelet function monitoring in patients with coronary artery disease. J Am Coll Cardiol. 2007 Nov 06; 50(19):1822-34.
Score: 0.041
-
Platelet Reactivity and Coagulation Markers in Patients with COVID-19. Adv Ther. 2021 07; 38(7):3911-3923.
Score: 0.026
-
Influence of Amlodipine on Haemostatic Measurements during Clopidogrel Treatment in Patients with Coronary Artery Disease. Thromb Haemost. 2019 Feb; 119(2):264-273.
Score: 0.022
-
Ticagrelor versus Clopidogrel in Peripheral Artery Disease. N Engl J Med. 2017 04 13; 376(15):1487-8.
Score: 0.020